A. Rees

Potent Cyclic Monomeric and Dimeric Peptide Inhibitors of VLA‐4 (α4β1 Integrin)‐Mediated Cell Adhesion Based on the Ile‐Leu‐Asp‐Val Tetrapeptide

P. Gellert, C. Reilly, L. Hassall, 2000 .

Identification and optimisation of 3,3-dimethyl-azetidin-2-ones as potent and selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)

S. Steinbacher, M. Augustin, D. Ogg, 2014 .

Structure-based design of protein tyrosine phosphatase-1B inhibitors.

Jon Read, Alexander L Breeze, A. Breeze, 2005, Bioorganic & medicinal chemistry letters.

Novel acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor with reduced acyl glucuronide liability: the discovery of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid (AZD8329).

Martin J Packer, Nidhal Selmi, Andrew Stocker, 2012, Journal of medicinal chemistry.

Discovery of a potent, selective, and orally bioavailable acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor: discovery of 2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic acid (AZD4017).

Martin J Packer, Nidhal Selmi, David Hargreaves, 2012, Journal of medicinal chemistry.

Reduction of acyl glucuronidation in a series of acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors: the discovery of AZD6925

James S. Scott, N. Selmi, M. Packer, 2012 .

Potent cyclic peptide inhibitors of VLA‐4 (α4β1 integrin)‐mediated cell adhesion. Discovery of compounds like cyclo(MePhe‐Leu‐Asp‐Val‐d‐Arg‐d‐Arg) (ZD7349) compatible with depot formulation

P. Gellert, L. Hassall, P. Alcock, 2000, Journal of peptide science : an official publication of the European Peptide Society.

Optimisation of pharmacokinetic properties in a neutral series of 11β-HSD1 inhibitors.

A. Gill, James S. Scott, J. Swales, 2012, Bioorganic & medicinal chemistry letters.

Novel acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor with reduced acyl glucuronide liability: the discovery of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid (AZD8329).

D. Hargreaves, D. Ogg, James S. Scott, 2012, Journal of medicinal chemistry.